Jacqulyne Robichaux
4PUBLICATIONS
33CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Sep 24, 2025
Poziotinib for EGFR exon 20-insertion NSCLC: Clinical efficacy of the phase 2 ZENITH trial and differential impact of EGFR exon 20 insertion location on sensitivity.Xiuning Le, Jacqulyne P Robichaux, Monique Nilsson
|Mar 18, 2025
Molecular residual disease analysis of adjuvant osimertinib in resected EGFR-mutated stage IB-IIIA non-small-cell lung cancer.Roy S Herbst, Thomas John, Christian Grohé
|Sep 22, 2021
Poziotinib for Patients With HER2 Exon 20 Mutant Non-Small-Cell Lung Cancer: Results From a Phase II Trial.Yasir Y Elamin, Jacqulyne P Robichaux, Brett W Carter
|Sep 04, 2020
A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components.Monique B Nilsson, Huiying Sun, Jacqulyne Robichaux
Pageof 1
Frequent Collaborators
3 joint publications
John V Heymach
2 joint publications
Yasir Y Elamin
2 joint publications
Don L Gibbons
2 joint publications
Marcelo V Negrao
2 joint publications
Xiuning Le
2 joint publications
Jonathan W Goldman
1 joint publications
Vincent K Lam
1 joint publications
Anisha B Patel
1 joint publications
Frank E Mott
1 joint publications
Jianjun Zhang
